Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells.

Dendritic cells (DC) are important accessory cells that are capable of initiating an immune response. Generation of functional DC has potential clinical use in treating diseases such as cancer. In this report, we have demonstrated the generation of functional DC from mononuclear cells isolated from human umbilical cord blood cells (UCBC) and peripheral blood cells (PBC) using a defined medium Prime Complete Growth Medium (PCGM) (GenePrime LLC, Gaithersburg, MD). DC generated using PCGM showed the typical phenotype of DC as determined by flow cytometry and electron microscopy. Further analysis of the DC using confocal microscopy showed localization of the antigen and major histocompatibility complex (MHC) molecules in the cytoplasm 3-5 days following tumor antigen loading into DC. Subsequently, the tumor antigen-MHC complex was localized on the surface of DC. DC generated from UCBC or PBC also increased (p < 0.001) the allogeneic mixed lymphocyte reaction, confirming their immune accessory functions compared to a control mixed lymphocyte reaction (MLR) without DC added. Interestingly, DC generated using PCGM medium also significantly enhanced the hematopoietic colony (CFU-C)-forming ability. Furthermore, addition of 5% DC derived from cord blood loaded with tumor antigen also significantly (p < 0.001) increased peripheral and cord blood-derived antigen-specific cytotoxic T lymphocyte (CTL)-mediated killing of human leukemic cells (K562) and breast cancer cells (MDA-231). Thus, these results show that functional DC generated from cord blood using a defined medium are a useful source of accessory cells for augmenting CTL-mediated cytotoxicity and have potential use in cellular therapy for human leukemia and breast cancer.

[1]  J. Salamero,et al.  In vitro production of dendritic cells from human blood monocytes for therapeutic use. , 2001, Journal of hematotherapy & stem cell research.

[2]  R. Steinman,et al.  Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus. , 1999, Blood.

[3]  J. Armitage,et al.  The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. , 1991, Blood.

[4]  K M Ardeshna,et al.  A Clinically Applicable Method for the ex vivo Generation of Antigen–Presenting Cells from CD34+ Progenitors , 2000, Vox Sanguinis.

[5]  R. Steinman,et al.  Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.

[6]  D. Davies,et al.  Human peripheral blood contains two distinct lineages of dendritic cells , 1999, European journal of immunology.

[7]  S. Glück,et al.  Effects of cytokines on the culture and differentiation of dendritic cells in vitro. , 2001, Journal of hematotherapy & stem cell research.

[8]  P. Iversen,et al.  Increased growth inhibition of human chronic myelogenous leukemic cells by a combination of c-myb antisense oligonucleotide and 4-hydroxyperoxycyclophosphamide in vitro. , 1997, International journal of oncology.

[9]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[10]  B. Pulendran,et al.  Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  K. Tadokoro,et al.  Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia. , 1998, Blood.

[12]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[13]  D. Harris.  In vitro and in vivo assessment of the graft-versus-leukemia activity of cord blood. , 1995, Bone marrow transplantation.

[14]  J. Kash,et al.  Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli. , 2001, Clinical immunology.

[15]  Y. Aizawa,et al.  Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. , 2000, Journal of hematotherapy & stem cell research.

[16]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[17]  A. Thomson,et al.  Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. , 1998, Transplantation.

[18]  J. Gaddy,et al.  Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[19]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[20]  C. Rooney,et al.  Autoimmune disease induced by dendritic cell immunization against leukemia. , 1999, Leukemia research.

[21]  K. Tarte,et al.  Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro , 2000, Leukemia.

[22]  J. Wagner,et al.  Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.

[23]  R. Steinman,et al.  Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo , 1993, The Journal of experimental medicine.

[24]  M. Bishop,et al.  Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells. , 1998, International journal of oncology.

[25]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[26]  B. Czerniecki,et al.  Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. , 1999, Journal of immunology.

[27]  S. Joshi,et al.  Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.